Literature DB >> 17629601

Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.

E Leuridan1, P Van Damme.   

Abstract

This paper reviews literature on passively transferred maternal antibodies against measles in infants. The amount and decay of these antibodies can be a result of changing patterns in society: increasing cohorts of women are vaccinated against measles instead of having naturally acquired immunity, the age of first childbirth is increasing and young adults are less exposed to natural boosters. The concentration and persistence of maternal antibodies differ in infants of women vaccinated against measles versus infants of naturally immune women. The date for commencing universal measles vaccination should take into account the presence of these antibodies since they can hamper the immunological response to vaccination. Each country should therefore consider adapting the timing of vaccination in relation to its measles sero-epidemiological situation. The possibility of priming the immune system with an early vaccine dose and boosting later on offers opportunities for vaccination at very young age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629601     DOI: 10.1016/j.vaccine.2007.06.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  42 in total

Review 1.  Measles Status-Barriers to Vaccination and Strategies for Overcoming Them.

Authors:  Constanze Storr; Linda Sanftenberg; Joerg Schelling; Ulrich Heininger; Antonius Schneider
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

2.  Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.

Authors:  Chuanxi Fu; Jichuan Shen; Long Lu; Yajing Li; Yimin Cao; Ming Wang; Sen Pei; Zhicong Yang; Qing Guo; Jeffrey Shaman
Journal:  Vaccine       Date:  2017-06-10       Impact factor: 3.641

3.  Ecological and life-history factors influencing the evolution of maternal antibody allocation: a phylogenetic comparison.

Authors:  Brianne Addison; Kirk C Klasing; W Douglas Robinson; Suzanne H Austin; Robert E Ricklefs
Journal:  Proc Biol Sci       Date:  2009-08-26       Impact factor: 5.349

Review 4.  Recent advances in vertebrate and invertebrate transgenerational immunity in the light of ecology and evolution.

Authors:  Olivia Roth; Anne Beemelmanns; Seth M Barribeau; Ben M Sadd
Journal:  Heredity (Edinb)       Date:  2018-06-18       Impact factor: 3.821

5.  Maternal mumps antibodies in a cohort of children up to the age of 1 year.

Authors:  E Leuridan; N Goeyvaerts; N Hens; V Hutse; P Van Damme
Journal:  Eur J Pediatr       Date:  2012-03-07       Impact factor: 3.183

6.  Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia.

Authors:  Amanda Demaster; Xiaoyan Luo; Sarah Curtis; Kyha D Williams; Dustin J Landau; Elizabeth J Drake; Daniel M Kozink; Andrew Bird; Bayley Crane; Francis Sun; Carlos R Pinto; Talmage T Brown; Alex R Kemper; Dwight D Koeberl
Journal:  Hum Gene Ther       Date:  2012-03-08       Impact factor: 5.695

7.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

8.  Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination.

Authors:  Hong Zhao; Pei-Shan Lu; Yali Hu; Qiaozhen Wu; Wenhu Yao; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-05-06       Impact factor: 4.099

9.  Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.

Authors:  Zaza M Ndhlovu; Monika Angenendt; Diana Heckel; Jonathan P Schneck; Diane E Griffin; Mathias Oelke
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

Review 10.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.